Koenig, A; Lange, K; Konter, J et al.
Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.J Cardiovasc Pharmacol. Bd. 50. H. 1. 2007 S. 68-74
Sinning, JM; Bickel, C; Sinning, C et al.
Procalcitonin for risk stratification in stable coronary artery disease: Results from the atherogene studyCirculation. Bd. 116. H. 16. 2007 S. 851
Morange, PE; Blankenberg, S; Alessi, MC et al.
Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.J Thromb Haemost. Bd. 5. 2007 S. 475-482
Fajadet, J; Wijns, W; Laarman, GJ et al.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.Minerva Cardioangiol. Bd. 55. H. 1. 2007 S. 1-18
Gori, T; Fineschi, M
Recurrent angina and the problem of inadequate/inappropriate revascularizationEur Heart J. Bd. 28. H. 23. 2007 S. 2951; author reply 2951-2
Gradaus, R; Seidl, K; Korte, T et al.
Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.Europace. Bd. 9. H. 7. 2007 S. 534-9
Lubos, E; Messow, CM; Schnabel, R et al.
Resistin, acute coronary syndrome and prognosis results from the AtheroGene study.Atherosclerosis. Bd. 193. 2007 S. 121-128
Bauersachs, RM; Dudenhausen, J; Faridi, A et al.
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.Thromb Haemost. Bd. 98. H. 6. 2007 S. 1237-45
Wenzel, P; Hink, U; Oelze, M et al.
Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance.J Biol Chem. Bd. 282. H. 1. 2007 S. 792-9
Fineschi, M; Gori, T; Pierli, C et al.
Symptomatic failure after sirolimus-eluting stent implantation: a rare but challenging condition.Can J Cardiol. Bd. 23. H. 2. 2007 S. 139-42
Münzel, T; Genth-Zotz, S; Hink, U
Targeting heme-oxidized soluble guanylate cyclase: solution for all cardiorenal problems in heart failure?Hypertension. Bd. 49. H. 5. 2007 S. 974-6
Daiber, A; Wenzel, P; Oelze, M et al.
vivo Studien zur Nitrattoleranz und Superoxidbildung: Vergleich der Wirkungen von Pentaerithrithyltetranitrat mit Nitroglyzerin.Erdmann, Lehmann und Lüderitz (Hrsg). Begleitband zum 13. PETN-Expertentreffen. Herausgeber Erdmann, Lehmann und Lüderitz, Steinkopff/Springer Verlag, Darmstadt, Deutschland. Darmstadt: Steinkopff/Springer verlag 2007
Scharnbacher, J; Reichert, J; Röhrl, T et al.
Welche Belastungen lösen ein Hypothenar-Hammer-Syndrom aus?Arbeits Sozial Umweltmed. Bd. 42. 2007 S. 113
von Mach, MA; Burhenne, J; Weilemann, LS
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.BMC Clin Pharmacol. Bd. 6. 2006 S. 6
Sperzel, J; Nowak, B; Himmrich, E et al.
Acute performance evaluation of a new ventricular automatic capture algorithm.Europace. Bd. 8. H. 1. 2006 S. 65-9
von Mach, MA; Kaes, J; Omogbehin, B et al.
An update on interventional lung assist devices and their role in acute respiratory distress syndrome.Lung. Bd. 184. H. 3. 2006 S. 169-75
Hoffmann, R; von Bardeleben, S; Kasprzak, JD et al.
Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods.J Am Coll Cardiol. Bd. 47. H. 1. 2006 S. 121-8
Lauterbach, M; Horstick, G; Kempf, T et al.
Anti-inflammatory treatment with standardized human serum protein solution reduces local and systemic inflammatory response after hemorrhagic shock.Eur Surg Res. Bd. 38. H. 4. 2006 S. 399-406
Schinzel, H; Berghoff, K; Beuermann, I et al.
Anticoagulation with low-molecular-weight heparin (dalteparin) in plasmapheresis therapy: initial experience.Transfusion. Bd. 46. H. 4. 2006 S. 624-9
von Mach, MA; Gauer, M; Meyer, S et al.
Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin.Int J Clin Pharmacol Ther. Bd. 44. H. 2. 2006 S. 51-6
Schinzel, H
Antithrombotika und FibrinollysetherapieInternistische TherapieWolff HP, Weihrauch TR (Hrsg). Internistische Therapie. 16. Aufl. Urban&Fischer -Elsevier 2006
Schnabel, R; Espinola-Klein, C; Messow, CM et al.
Association of adiponectin with adverse outcome in manifest coronary artery diseaseCirculation. Bd. 114. H. 18. 2006 S. 222 Suppl S
Kettering, K; Al-Ghobainy, R; Wehrmann, M et al.
Atrial linear lesions: feasibility using cryoablation.Pacing Clin Electrophysiol. Bd. 29. H. 3. 2006 S. 283-9
Schnabel, R; Lubos, E; Rupprecht, HJ et al.
B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.J Am Coll Cardiol. Bd. 47. 2006 S. 552-558
Kettering, K; Greil, GF; Busch, M et al.
Catheter ablation of atrial fibrillation: ongoing atrial fibrillation inside a single pulmonary vein after successful electrical disconnection and restoration of sinus rhythm in both atria.Clin Res Cardiol. Bd. 95. H. 12. 2006 S. 663-7
Blankenberg, S; McQueen, MJ; Smieja, M et al.
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.Circulation. Bd. 114. H. 3. 2006 S. 201-8
Hink, U; Münzel, T
COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?Circ Res. Bd. 98. H. 11. 2006 S. 1344-1346
Kleschyov, AL; Strand, S; Schmitt, S et al.
Dinitrosyl-iron triggers apoptosis in Jurkat cells despite overexpression of Bcl-2Free Radical Bio Med. Bd. 40. H. 8. 2006 S. 1340-1348
Förstermann, U; Münzel, T
Endothelial nitric oxide synthase in vascular disease: from marvel to menace.Circulation. Bd. 113. H. 13. 2006 S. 1708-14
Wenzel, J; Lubos, E; Schnabel, R et al.
Evaluation of eNOS polymorphisms and the risk of future cardiovascular events in the AtheroGene studyEur Heart J. Bd. 27. 2006 S. 129 Suppl 1
Schnabel, R; Messow, CM; Lubos, E et al.
FLT-1 as an early diagnostic marker in acute coronary syndromes (Group Author(s): AtheroGene)Eur Heart J. Bd. 27. 2006 S. 152 Suppl 1
Schlitt, A; Blankenberg, S; Yan, D et al.
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.Nutr Metab Cardiovasc Dis. Bd. 3. 2006 S. 5
Morange, PE; Bickel, C; Nicaud, V et al.
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease.Arterioscler Thromb Vasc Biol. Bd. 26. 2006 S. 2793-2799
Blankenberg, S; Godefroy, T; Poirier, O et al.
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.Circ Res. Bd. 99. 2006 S. 102-108
Sinning, JM; Bickel, C; Messow, CM et al.
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.Eur Heart J. Bd. 27. H. 24. 2006 S. 2962-8
Baldus, S; Mullerleile, K; Chumley, P et al.
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.Free Radic Biol Med. Bd. 41. H. 8. 2006 S. 1282-1288
von Mach, MA; Habermehl, P; Zepp, F et al.
Intoxikationen mit Medikamenten im Kindesalter bei einem regionalen Giftinformationszentrum.Klin Padiatr. Bd. 218. H. 1. 2006 S. 31-3
August, M; Wingerter, O; Oelze, M et al.
Mechanisms underlying dysfunction of carotid arteries in genetically hyperlipidemic rabbits.Nitric Oxide. Bd. 15. H. 3. 2006 S. 241-251
Peetz, D; Schweigert, R; Jachmann, N et al.
Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.Clin Lab. Bd. 52. H. 11-12. 2006 S. 605-14
Mollnau, H; Wenzel, P; Oelze, M et al.
Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.BMC Cardiovasc Disord. Bd. 6. 2006 S. 44
Oelze, M; Warnholtz, A; Faulhaber, J et al.
NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.Arterioscler Thromb Vasc Biol. Bd. 26. H. 8. 2006 S. 1753-9
Oelze, M; Daiber, A; Brandes, RP et al.
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.Hypertension. Bd. 48. H. 4. 2006 S. 677-84
Schinzel, H
Niedermolekulare Heparine in der IntensivmedizinS. Haas (Hrsg). Niedermolekulare Heparine. Springer 2006
Volz, S; Schinzel, H; Keune, N et al.
Niedermolekulares Heparin bei Fruhgeborenen mit hereditaren Risikofaktoren und venosen Thrombosen.Klin Padiatr. Bd. 218. H. 4. 2006 S. 226-9
Munzel, TF; Post, F
Pathogenese und Therapie des akuten Koronarsyndroms differenzieller Nutzen von GPIIb/IIIa-Rezeptorantagonisten bei Hochrisikopatienten.Dtsch Med Wochenschr. Bd. 131. H. 47 Suppl 7. 2006 S. S215-8
Vollmann, D; Erdogan, A; Himmrich, E et al.
Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.Europace. Bd. 8. H. 5. 2006 S. 371-6
Bierbach, B; Horstick, G; Berg, O et al.
Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.J Thromb Haemost. Bd. 95. H. 2. 2006 S. 354-61
Lubos, E; Schnabel, R; Rupprecht, HJ et al.
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene studyEur Heart J. Bd. 27. H. 2. 2006 S. 150-6
Fajadet, J; Wijns, W; Laarman, GJ et al.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.Circulation. Bd. 114. H. 8. 2006 S. 798-806
Lubos, E; Messow, CM; Schnabel, R et al.
Resistin, acute coronary syndrome and prognosis: Results from the AtheroGene studyCirculation. Bd. 114. H. 18. 2006 S. 422 Suppl S